STUDY OBJECTIVE: The aim of this study was to analyze the role of dysphagia as a model of pharyngeal muscle dysfunction in the time course of nocturnal disordered breathing (NDB) in patients who experienced a first-ever ischemic stroke. DESIGN: Prospective study. PATIENTS AND INTERVENTIONS: Fifty-nine consecutive patients (mean age, 73.2 years; SD, 12.8 years) were studied. Clinical sleep and neurologic data and vascular risk factors were recorded. Two nocturnal studies using a portable autotitration device (AutoSet Portable Plus II system; ResMed; Sydney, NSW, Australia) were performed in both the acute phase (mean duration, 1.23 days; SD, 0.7 day) and the stable phase (mean duration 65.9 days; SD, 12.5 days) of the neurologic event in all patients. RESULTS: The mean total apnea-hypopnea index (AHI) measured with the autotitration device in the acute phase was 34.9 (SD, 25.2) vs 20.1 (SD, 21.7) in the stable phase, both with predominance of obstructive apnea. Patients with dysphagia (n = 30) showed the largest number of obstructive apneic episodes (OAIs) in the acute phase (AHI, 40 episodes; OAI, 30.4 episodes), with a significant reduction in this type of apnea during the stable phase of stroke (AHI, 24.7 episodes; OAI, 17.7 episodes), coinciding with the recovery of pharyngeal muscle function. In contrast, nondysphagic patients (n = 29) showed no significant changes in NDB from the acute to the stable phase of stroke. Logistic regression analysis found dysphagia to be the best independent predictor of AHI reduction of > 50% from baseline (odds ratio, 13.4; 95% confidence interval, 3.3 to 39.6; p = 0.001). CONCLUSION: The present study shows significant improvement in the number obstructive apneic events occurring in the stable phase of a first-ever ischemic stroke in patients with transient pharyngeal muscle alterations secondary to the neurologic lesion.
STUDY OBJECTIVE: The aim of this study was to analyze the role of dysphagia as a model of pharyngeal muscle dysfunction in the time course of nocturnal disordered breathing (NDB) in patients who experienced a first-ever ischemic stroke. DESIGN: Prospective study. PATIENTS AND INTERVENTIONS: Fifty-nine consecutive patients (mean age, 73.2 years; SD, 12.8 years) were studied. Clinical sleep and neurologic data and vascular risk factors were recorded. Two nocturnal studies using a portable autotitration device (AutoSet Portable Plus II system; ResMed; Sydney, NSW, Australia) were performed in both the acute phase (mean duration, 1.23 days; SD, 0.7 day) and the stable phase (mean duration 65.9 days; SD, 12.5 days) of the neurologic event in all patients. RESULTS: The mean total apnea-hypopnea index (AHI) measured with the autotitration device in the acute phase was 34.9 (SD, 25.2) vs 20.1 (SD, 21.7) in the stable phase, both with predominance of obstructive apnea. Patients with dysphagia (n = 30) showed the largest number of obstructive apneic episodes (OAIs) in the acute phase (AHI, 40 episodes; OAI, 30.4 episodes), with a significant reduction in this type of apnea during the stable phase of stroke (AHI, 24.7 episodes; OAI, 17.7 episodes), coinciding with the recovery of pharyngeal muscle function. In contrast, nondysphagic patients (n = 29) showed no significant changes in NDB from the acute to the stable phase of stroke. Logistic regression analysis found dysphagia to be the best independent predictor of AHI reduction of > 50% from baseline (odds ratio, 13.4; 95% confidence interval, 3.3 to 39.6; p = 0.001). CONCLUSION: The present study shows significant improvement in the number obstructive apneic events occurring in the stable phase of a first-ever ischemic stroke in patients with transient pharyngeal muscle alterations secondary to the neurologic lesion.
Authors: Devin L Brown; Chengwei Li; Brisa N Sánchez; Galit Levi Dunietz; Ronald D Chervin; Erin Case; Nelda M Garcia; Lynda D Lisabeth Journal: J Clin Sleep Med Date: 2018-05-15 Impact factor: 4.062
Authors: Devin L Brown; Ronald D Chervin; John D Kalbfleisch; Michael J Zupancic; Erin M Migda; Anna Svatikova; Maryann Concannon; Cory Martin; Kevin J Weatherwax; Lewis B Morgenstern Journal: J Stroke Cerebrovasc Dis Date: 2011-07-23 Impact factor: 2.136
Authors: Marc Bonnin-Vilaplana; Adrià Arboix; Olga Parra; Luis García-Eroles; Josep M Montserrat; Joan Massons Journal: J Neurol Date: 2009-12 Impact factor: 4.849
Authors: Devin L Brown; Mollie McDermott; Ashkan Mowla; Lindsey De Lott; Lewis B Morgenstern; Kevin A Kerber; Garnett Hegeman; Melinda A Smith; Nelda M Garcia; Ronald D Chervin; Lynda D Lisabeth Journal: Sleep Med Date: 2014-05-02 Impact factor: 3.492
Authors: Seong Hwan Ahn; Jin Ho Kim; Dong Uk Kim; In Seong Choo; Hyun Jin Lee; Hoo Won Kim Journal: J Clin Neurol Date: 2013-01-03 Impact factor: 3.077
Authors: Oleg Y Chernyshev; David E McCarty; Douglas E Moul; Cesar Liendo; Gloria C Caldito; Sai K Munjampalli; Roger E Kelley; Andrew L Chesson Journal: Nat Sci Sleep Date: 2015-10-20